Mezyran 25 mg tablete s produljenim oslobađanjem
| Name | Mezyran 25 mg tablete s produljenim oslobađanjem |
|---|---|
| Marketing Authorisation Number | HR-H-953308426 |
| Active Substance | mirabegron |
| Composition | jedna tableta sadrži 25 mg mirabegrona |
| Pharmaceutical Form | Tableta s produljenim oslobađanjem |
| Manufacturer | Pharmadox Healthcare Limited, Paola, Malta
Adalvo Limited, San Gwann, Malta |
| Marketing Authorisation Holder | Alpha-Medical d.o.o., Dragutina Golika 36, Zagreb, Hrvatska |
| Marketing Authorisation Date | 28.01.2026 |
| MA Period of Validity | 28.01.2031 |
| Classification Number | UP/I-530-09/24-01/375 |
| Registration Number | 381-12-01/70-26-26 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | G04BD12 |
| Marketing status | Never marketed |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Summary of risk management plan | download |
